CR Stock Analysis: Crane | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 12.620m USD | 12M Return: 9.2% | US2244081046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 95.8M
EPS Trend: 82.5%
Qual. Beats: 5
Rev. Trend: 90.8%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 3.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crane Company (NYSE: CR) is a U.S.-based industrial manufacturer of engineered products operating across two main segments. Its Aerospace & Advanced Technologies segment supplies OEM and aftermarket components for commercial aerospace, military aerospace, defense, and space markets, including pressure sensors for engine control, aircraft braking systems, defense and space power conversion solutions, and lubrication systems. The Process Flow Technologies segment manufactures process and commercial valves, pumps, valve positioning and control systems, vacuum insulated pipe systems, and valve diagnostic and calibration equipment. The company serves customers in the U.S., Canada, the U.K., Continental Europe, and other international markets. Originally founded in 1855 and headquartered in Stamford, Connecticut, Crane operates a diversified, B2B-focused business model serving highly regulated aerospace, defense, and industrial process end-markets, which typically involve long product certification cycles and recurring aftermarket service revenue.
- Commercial aerospace aftermarket recovery fuels segment growth
- Defense spending surge lifts Aerospace & Electronics backlog
- Process Flow Technologies margins expand on price actions
| Net Income: 336.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -4.93 > 1.0 |
| NWC/Revenue: 36.73% < 20% (prev 36.03%; Δ 0.70% < -1%) |
| CFO/TA 0.08 > 3% & CFO 328.9m > Net Income 336.1m |
| Net Debt (843.1m) to EBITDA (558.2m): 1.51 < 3 |
| Current Ratio: 2.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.7m) vs 12m ago 0.34% < -2% |
| Gross Margin: 41.74% > 18% (prev 41.32%; Δ 0.43% > 0.5%) |
| Asset Turnover: 79.16% > 50% (prev 90.44%; Δ -11.29% > 0%) |
| Interest Coverage Ratio: 13.32 > 6 (EBIT TTM 478.1m / Interest Expense TTM 35.9m) |
| A: 0.24 (Total Current Assets 1.48b - Total Current Liabilities 527.5m) / Total Assets 4.03b |
| B: 0.41 (Retained Earnings 1.67b / Total Assets 4.03b) |
| C: 0.15 (EBIT TTM 478.1m / Avg Total Assets 3.27b) |
| D: 1.18 (Book Value of Equity 2.18b / Total Liabilities 1.85b) |
| Altman-Z'' = 5.11 = AAA |
| DSRI: 0.93 (Receivables 487.6m/460.1m, Revenue 2.59b/2.28b) |
| GMI: 0.99 (GM 41.32% / 41.74%) |
| AQI: 1.36 (AQ_t 0.54 / AQ_t-1 0.40) |
| SGI: 1.14 (Revenue 2.59b / 2.28b) |
| TATA: 0.00 (NI 336.1m - CFO 328.9m) / TA 4.03b) |
| Beneish M = -2.78 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at USD 208.41 with a total of 293,558 shares traded. Over the past week, the price has changed by -4.55%, over one month by -4.44%, over three months by +14.83% and over the past year by +9.16%.
Current recommended Stop Loss: 200.30 (which is 3.9% or 1.3 ATR below the current price).
Crane has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CR.
- StrongBuy: 5
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 238 | 14.2% |
P/E Trailing = 38.1713
P/E Forward = 31.4465
P/S = 4.8702
P/B = 5.7954
P/EG = 2.7842
Revenue TTM = 2.59b USD
EBIT TTM = 478.1m USD
EBITDA TTM = 558.2m USD
Long Term Debt = 1.15b USD (from longTermDebt, last fiscal year)
Short Term Debt = 28.6m USD (from shortTermDebt, last quarter)
Debt = 1.19b USD (corrected: LT Debt 1.15b + ST Debt 28.6m) + Leases 16.7m
Net Debt = 843.1m USD (calculated: Debt 1.19b - CCE 350.4m)
Enterprise Value = 13.5b USD (12.6b + Debt 1.19b - CCE 350.4m)
Interest Coverage Ratio = 13.32 (Ebit TTM 478.1m / Interest Expense TTM 35.9m)
EV/FCF = 48.01x (Enterprise Value 13.5b / FCF TTM 280.4m)
FCF Yield = 2.08% (FCF TTM 280.4m / Enterprise Value 13.5b)
FCF Margin = 10.82% (FCF TTM 280.4m / Revenue TTM 2.59b)
Net Margin = 12.97% (Net Income TTM 336.1m / Revenue TTM 2.59b)
Gross Margin = 41.74% ((Revenue TTM 2.59b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 42.43% (prev 40.39%)
Tobins Q-Ratio = 3.34 (Enterprise Value 13.5b / Total Assets 4.03b)
Interest Expense / Debt = 3.01% (Interest Expense 35.9m / Debt 1.19b)
Taxrate = 24.05% (106.4m / 442.5m)
NOPAT = 363.1m (EBIT 478.1m * (1 - 24.05%))
Current Ratio = 2.80 (Total Current Assets 1.48b / Total Current Liabilities 527.5m)
Debt / Equity = 0.55 (Debt 1.19b / totalStockholderEquity, last quarter 2.18b)
Debt / EBITDA = 1.51 (Net Debt 843.1m / EBITDA 558.2m)
Debt / FCF = 3.01 (Net Debt 843.1m / FCF TTM 280.4m)
Total Stockholder Equity = 2.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.27% (Net Income 336.1m / Total Assets 4.03b)
RoE = 16.19% (Net Income TTM 336.1m / Total Stockholder Equity 2.08b)
RoCE = 14.83% (EBIT 478.1m / Capital Employed (Equity 2.08b + L.T.Debt 1.15b))
RoIC = 10.67% (NOPAT 363.1m / Invested Capital 3.40b)
WACC = 9.82% (E(12.6b)/V(13.8b) * Re(10.53%) + D(1.19b)/V(13.8b) * Rd(3.01%) * (1-Tc(0.24)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.54 | Cagr: 0.46%
[DCF] Terminal Value 69.45% ; FCFF base≈287.9m ; Y1≈273.9m ; Y5≈260.6m
[DCF] Fair Price = 42.34 (EV 3.29b - Net Debt 843.1m = Equity 2.45b / Shares 57.8m; r=9.82% [WACC]; 5y FCF grow -6.25% → 2.50% )
EPS Correlation: 82.53 | EPS CAGR: 14.57% | SUE: 2.33 | # QB: 5
Revenue Correlation: 90.78 | Revenue CAGR: 11.88% | SUE: 1.77 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.80 | Chg30d=+2.04% | Revisions=+44% | Analysts=8
EPS current Year (2026-12-31): EPS=6.99 | Chg30d=+2.61% | Revisions=+70% | GrowthEPS=+15.5% | GrowthRev=+25.4%
EPS next Year (2027-12-31): EPS=7.80 | Chg30d=+2.27% | Revisions=+36% | GrowthEPS=+11.7% | GrowthRev=+5.6%
[Analyst] Revisions Ratio: +62% (up=18, down=3)